Loading company…
Pleasanton-based company developing microfluidic liquid biopsy systems to capture and analyze circulating tumor cells.
Founded in 2010 and headquartered in Pleasanton, US, Vortex Biosciences develops liquid biopsy systems for capturing and analyzing circulating tumor cells (CTCs) from whole blood. Its flagship VTX-1 Liquid Biopsy System uses microfluidic technology with the Vortex Cartridge, and revenue comes from equipment sales and consumables. Customers are institutions and biopharmaceutical companies in oncology research across North America, Europe and Asia. The company raised funding from EMV Capital in April 2019.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in